Search Results 1831-1840 of 14846 for anti-TNF drugs

  1. Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction - Mayo Clinic

    Use of an investigational anti-cancer drug within 28 days preceding the first dose of dabrafenib; Patients receiving any medications or substances that are ...

  2. Talc (Intrapleural Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Sclerosol Intrapleural; Steritalc. Descriptions.

  3. Interferon Beta-1a (Intramuscular Route, Subcutaneous Route) Precautions - Mayo Clinic

    Precautions. Drug information provided by: Merative, Micromedex®. It is very important that your doctor check your progress at regular visits to make sure ...

  4. Overview - Systems Biology and Translational Medicine: Akhilesh Pandey - Mayo Clinic Research

    Our goal is to apply multi-omics technologies for improving and individualizing diagnosis and treatment of cancer and other conditions. Overview. The Systems ...

  5. Romidepsin in Treating Patients with Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors with Liver Dysfunction - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... anti-cancer therapy including chemotherapy ...

  6. Technetium Tc 99m Sulfurcolloid (Injection Route, Route Not Applicable) Description and Brand Names - Mayo Clinic

    Technetium Tc 99m sulfur colloid injection is a radiopharmaceutical. Radiopharmaceuticals are radioactive agents, which may be used to find and treat certain ...

  7. Tofacitinib (Oral Route) Description and Brand Names - Mayo Clinic

    Tofacitinib is used alone or together with other medicines (eg, DMARDs) to treat moderate to severely active rheumatoid arthritis, active psoriatic arthritis, ...

  8. Nilutamide (Oral Route) Description and Brand Names - Mayo Clinic

    Descriptions. Nilutamide is used with surgery to treat metastatic prostate cancer (cancer that has spread) in men. Nilutamide belongs to the group of medicines ...

  9. Phase 1 Study of SPX-303 in Solid Tumors - Mayo Clinic

    Treatment with anti neoplastic therapy ≤ 28 days or ≤ 5× elimination half life, whichever is shorter, before the first dose of study drug. 4. Major ...

  10. A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction - Mayo Clinic

    This is a double-blind, sham-controlled clinical study to evaluate the safety and feasibility of AMI MultiStem therapy in subjects who have had a heart attack ( ...